Use of Reticulated Open Cell Foam Dressings With Through Holes During Negative Pressure Wound Therapy With Instillation and Dwell Time

A Large Case Study

Luis G. Fernández, MD, FACS, FASAS, FCCP, FCCM, FICS; Marc R. Matthews, MD, MS, MC, FACS; Cynthia Ellman, RN, BSN, CWOCN; Patricia Jackson, BSN, RN, CWOCN; David H. Villarreal, MD, FACS; Scott Norwood, MD, FACS, FCCM

Disclosures

Wounds. 2020;32(10):279-282. 

In This Article

Materials and Methods

All patients underwent clinical evaluation and wound assessment upon presentation at a tertiary referral, level I trauma center. Oral and/or intravenous (IV) antibiotic treatment was initiated in patients as needed. Of the 19 wounds, 8 underwent sharp debridement prior to initiation of NPWTi-d and ROCF-CC. The remaining patients (n = 11) were not candidates for sharp debridement due to increased operative risk associated with the patient's clinical statuses and comorbidities.

All patients received NPWTi-d (V.A.C. VERAFLO Therapy; KCI, now part of 3M Company) using an ROCF-CC dressing (V.A.C. VERAFLO CLEANSE CHOICE Dressing; KCI, now part of 3M Company). The ROCF-CC dressing was cut to fit the wound and then placed in the wound bed. If needed, the cover layer was cut to fit the wound and applied over the ROCF-CC dressing. A drape was placed over the dressings, and the tubing (V.A.C. VERAT.R.A.C. DUO Tube Set; KCI, now part of 3M Company) was attached to the therapy unit. Institutional guidelines were followed in the selection of instillation solution. Wounds that were suspected of infection received either quarter-strength Dakin's solution or hypochlorous acid solution. Instillation of quarter-strength Dakin's solution, hypochlorous acid solution, or saline with a dwell time of 5 to 10 minutes, followed by 2 to 3.5 hours of continuous negative pressure at -125 mm Hg were initiated. Dressing changes occurred every 2 to 3 days.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....